Valor20202021202220232024Total de passivos36.39 M35.88 M35.5 M34.11 M39.55 MCapital total57.15 M32.19 M15.3 M5.42 M-865 KTotal de passivos e patrimônio líquido93.54 M68.06 M50.8 M39.53 M38.68 MDívida total23.85 M21.68 M23.53 M24.03 M27.29 MDívida líquida-64.37 M11.91 M18.17 M-6.85 M5.38 M
Pluri Inc. - Common Stock
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.